MX347154B - Prueba de diagnóstico para enfermedades infecciosas en ganado bovino. - Google Patents

Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.

Info

Publication number
MX347154B
MX347154B MX2012003180A MX2012003180A MX347154B MX 347154 B MX347154 B MX 347154B MX 2012003180 A MX2012003180 A MX 2012003180A MX 2012003180 A MX2012003180 A MX 2012003180A MX 347154 B MX347154 B MX 347154B
Authority
MX
Mexico
Prior art keywords
infectious diseases
bovine
characteristic
cattle
protein
Prior art date
Application number
MX2012003180A
Other languages
English (en)
Other versions
MX2012003180A (es
Inventor
Fedorovish Licea Navarro Alexei
Félix Olivares Quintero José
Paola Gutiérrez Ordoñez Ana
Original Assignee
Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) filed Critical Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese)
Priority to MX2012003180A priority Critical patent/MX347154B/es
Priority to US14/380,863 priority patent/US9284360B2/en
Priority to PCT/MX2013/000025 priority patent/WO2013125936A2/es
Publication of MX2012003180A publication Critical patent/MX2012003180A/es
Publication of MX347154B publication Critical patent/MX347154B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una proteína de fusión caracterizada porque se compones de: a) una proteína que contiene la secuencia SEQ ID NO. 2; y, b) un antígeno de enfermedades infecciosas, en donde el antígeno de la enfermedad infecciosa comprende una proteína.
MX2012003180A 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino. MX347154B (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2012003180A MX347154B (es) 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
US14/380,863 US9284360B2 (en) 2012-02-24 2013-02-21 Diagnostic test for infectious diseases in cattle
PCT/MX2013/000025 WO2013125936A2 (es) 2012-02-24 2013-02-21 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012003180A MX347154B (es) 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.

Publications (2)

Publication Number Publication Date
MX2012003180A MX2012003180A (es) 2013-08-27
MX347154B true MX347154B (es) 2017-02-21

Family

ID=49006336

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003180A MX347154B (es) 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.

Country Status (3)

Country Link
US (1) US9284360B2 (es)
MX (1) MX347154B (es)
WO (1) WO2013125936A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020005704A (es) * 2020-07-13 2022-01-14 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Secuencias de dominios vnar de potamotrygon spp. como inmunoacarreadores anti-cancer.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219562D0 (en) 1992-03-11 1992-10-28 Prendergast Kennet F Anti-viral peptides
JPH07506727A (ja) * 1992-05-22 1995-07-27 アジェン・リミテッド 凝集アッセイ用試薬
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
PL202844B1 (pl) 1998-04-07 2009-07-31 Corixa Corp Immunogeniczny polipeptyd, polinukleotyd, polipeptyd, kompozycja farmaceutyczna, wektor ekspresji, kompozycja szczepionki, polipeptyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis, polinukleotyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis i sposób wytwarzania polipeptydu
DK1144447T3 (da) 1998-11-04 2010-02-08 Isis Innovation Dianostisk tuberkulosetest
US7083796B2 (en) 2000-06-20 2006-08-01 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
JP2008511286A (ja) 2004-06-02 2008-04-17 ダイアテック・ピーティワイ・リミテッド サメ類のＩｇＮＡＲドメインに基づく結合成分
US20060024332A1 (en) 2004-08-02 2006-02-02 Waters Wade R Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
WO2011056056A2 (es) * 2009-11-04 2011-05-12 Laboratorios Silanes, S.A. De C.V. Dominios vhnar anti -citocinas

Also Published As

Publication number Publication date
MX2012003180A (es) 2013-08-27
WO2013125936A2 (es) 2013-08-29
US20150044689A1 (en) 2015-02-12
WO2013125936A9 (es) 2014-03-13
WO2013125936A3 (es) 2013-10-24
US9284360B2 (en) 2016-03-15

Similar Documents

Publication Publication Date Title
EP4296673A3 (en) Peptides and methods for the detection of lyme disease antibodies
WO2011063003A3 (en) Peptides and methods for the detection of lyme disease antibodies
MX348071B (es) Variantes de fc.
NZ734803A (en) Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
MX381183B (es) Proteínas de fusión de serpina-fc de inmunoglobulina de humano y método de purificación de las mismas.
MY171913A (en) Methods for determining ligand binding to a target protein using a thermal shift assay
EA201490745A1 (ru) Полипептиды антител, которые вызывают антагонизм cd40l
ECSP12012272A (es) Proteínas que se unen al tnf-?
HK1252653A1 (zh) 特异於人hla呈递的ebv潜伏膜蛋白2a肽的t细胞受体样抗体药剂
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
EA201591020A1 (ru) Человеческие анти-тау антитела
SG10201804124XA (en) Recombinant cell surface capture proteins
WO2011002968A3 (en) Polypeptides and method of treatment
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
WO2012046061A3 (en) Clostridium difficile antigens
AU2018249796A1 (en) Antibody Fc variants for improving blood half-life
WO2011156467A3 (en) Methods of detecting residual amounts of polymers used in the purification of biomolecules
BR112014023063A2 (pt) anticorpos que neutralizam rsv, mpv e pvm e usos dos mesmos
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
WO2012126118A8 (en) Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
WO2013138259A3 (en) Polypeptides for treating and/or limiting influenza infection
MX347154B (es) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
MX2015011931A (es) Expresion mejorada de proteinas de picornavirus.
WO2011015379A8 (en) Human hcv-interacting proteins and methods of use
PH12012000361B1 (en) Method for detecting flaviviridae virus infection

Legal Events

Date Code Title Description
FG Grant or registration